Cathy Eng, VICC Associate Director of Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, shared on X:
“Great opening lecture for OLN Great Debates in Solid Tumors from Vivek Subbiah: the need for increasing tumor agnostic approval for improved access.”
To which, Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, added:
“Kicked off the opening plenary at Great Debates in Solid Tumors today in NYC. Even the rain helped keeping a full house engaged on a Saturday in Times Sqaure NY, so they could all be engaged in a powerful call to advance tumor‑agnostic precision medicine. The Q&A turned out to be on the hottest issues and showed just how ready the field is to accelerate.
Huge thanks to the organizers and for the invite and Cathy Eng for the moderation, an amazing session all around.”
You can also read ‘Guru Sonpavde: Honored to Participate as Faculty in OLN Great Debates in Solid Tumors‘
